The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...

The Supreme Court on Friday upheld the structure of a federal health task force that recommends preventive medical services ...

The Food and Drug Administration has approved a new drug that could prevent HIV infections with just two shots every year and ...

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...

In clinical trials, researchers found Yeztugo to be highly effective as a twice-yearly form of pre-exposure prophylaxis.

Lenacapavir, a twice-yearly HIV prevention shot by Gilead, could be produced for $25 a year but may sell for $25K, raising ...

As with many chronic and often deadly diseases, an ounce of prevention can be worth a ton of cure. It's a breakthrough drug ...

A newly approved HIV medication provides near-total protection against infection with just two injections a year. It's called Lenacapavir. But the high price of the drug could limit its reach.

A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One ...

But the Trump administration’s cuts to HIV programs in the U.S. and abroad could undermine the drug’s rollout.